TYR and melanoma: In another study (Curry et al, 1998) where blood samples from 276 melanoma patients were tested for tyrosinase and MART-1 at multiple sequential time points for at least 2 years after surgery, a low incidence of RT–PCR positivity was observed even up to 2 years after surgery.